Abstract

MsrB1 used to be named selenoprotein R, for it was first identified as a selenocysteine containing protein by searching for the selenocysteine insert sequence (SECIS) in the human genome. Later, it was found that MsrB1 is homologous to PilB in Neisseria gonorrhoeae, which is a methionine sulfoxide reductase (Msr), specifically reducing L-methionine sulfoxide (L-Met-O) in proteins. In humans and mice, four members constitute the Msr family, which are MsrA, MsrB1, MsrB2, and MsrB3. MsrA can reduce free or protein-containing L-Met-O (S), whereas MsrBs can only function on the L-Met-O (R) epimer in proteins. Though there are isomerases existent that could transfer L-Met-O (S) to L-Met-O (R) and vice-versa, the loss of Msr individually results in different phenotypes in mice models. These observations indicate that the function of one Msr cannot be totally complemented by another. Among the mammalian Msrs, MsrB1 is the only selenocysteine-containing protein, and we recently found that loss of MsrB1 perturbs the synaptic plasticity in mice, along with the astrogliosis in their brains. In this review, we summarized the effects resulting from Msr deficiency and the bioactivity of selenium in the central nervous system, especially those that we learned from the MsrB1 knockout mouse model. We hope it will be helpful in better understanding how the trace element selenium participates in the reduction of L-Met-O and becomes involved in neurobiology.

Highlights

  • The oxidation of free L-methionine (L-Met) to L-methionine sulfoxide (L-Met-O) by chemical agents, such as iodine, iodate, and hydrogen peroxide, was first demonstrated in1938 [1]

  • These observations indicate that L-Met-O but not sulfone could probably be converted back into L-Met in a mechanism, which was unknown at that point

  • Further study showed that the consequence of L-Met oxidation of many proteins inhibited their functions [5,6], and there is a thioredoxin- (Trx) and thioredoxin reductase (TXNRD)-dependent mechanism that could convert L-Met-O back to L-Met [7,8]

Read more

Summary

Introduction

The oxidation of free L-methionine (L-Met) to L-methionine sulfoxide (L-Met-O) by chemical agents, such as iodine, iodate, and hydrogen peroxide, was first demonstrated in. Because free L-Met-O is unable to be inserted into polypeptides during protein synthesis, because methionyl-tRNA synthetase does not recognize it [3] These observations indicate that L-Met-O but not sulfone could probably be converted back into L-Met in a mechanism, which was unknown at that point. Further study showed that the consequence of L-Met oxidation of many proteins inhibited their functions [5,6], and there is a thioredoxin- (Trx) and thioredoxin reductase (TXNRD)-dependent mechanism that could convert L-Met-O back to L-Met [7,8]. In 1981, scientists obtained an enzyme which could reduce L-Met-O when they were studying the Escherichia coli. In 1981, scientists obtained an enzyme which could reduce L-Met-O when they were studying the Escherichia coli (E. coli) ribosome protein 12, a protein which loses its activity upon oxidation of selected LMet residues by hydrogen [9].

Loss of Msr
Deficiency of Selenium or Selenoproteins Results in Disfunction of the Brain
Findings
Perspectives
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.